These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2624388)

  • 21. Enuresis.
    Robson WL
    Adv Pediatr; 2001; 48():409-38. PubMed ID: 11480766
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
    Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
    J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of oxybutynin, pseudoephedrine and indomethacin in the treatment of primary nocturnal enuresis.
    Varan B; Saatçi U; Ozen S; Bakkaloğlu A; Beşbaş N
    Turk J Pediatr; 1996; 38(2):155-9. PubMed ID: 8701478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enuresis. Results of a new therapeutic approach].
    Luque Arana JI; Perales Cabanas L
    Actas Urol Esp; 1989; 13(6):432-5. PubMed ID: 2618833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hallucinations after hypospadias repair.
    Swana HS; Youmans SL; Kogan BA; Bogetz MS
    J Pediatr Surg; 2006 Mar; 41(3):e33-5. PubMed ID: 16516613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of an intravesial oxybutynin chloride solution: from formulation to quality control].
    Fratta A; Bordenave J; Boissinot C; Le Grand J; Esquirol C; Radideau E; Benoit G
    Ann Pharm Fr; 2005 Mar; 63(2):162-6. PubMed ID: 15976684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oxybutynin chloride in pediatrics: extenuating circumstances].
    Aubert D
    Arch Fr Pediatr; 1988 May; 45(5):375-6. PubMed ID: 3415420
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of oxybutynin hydrochloride in the treatment of enuresis nocturna--a clinical and urodynamic study.
    Koşar A; Arikan N; Dinçel C
    Scand J Urol Nephrol; 1999 Apr; 33(2):115-8. PubMed ID: 10360452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuropsychiatric adverse effects attributed to use of oxybutynin].
    t'Veld BA; Kwee-Zuiderwijk WJ; van Puijenbroek EP; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Mar; 142(11):590-2. PubMed ID: 9623118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An update on clinical and therapeutic aspects of nocturnal enuresis].
    Chiozza ML
    Pediatr Med Chir; 1997; 19(5):385-90. PubMed ID: 9493232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxybutynin chloride (Ditropan) in enuresis.
    Buttarazzi PJ
    J Urol; 1977 Jul; 118(1 Pt 1):46. PubMed ID: 875196
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia.
    Painter KA; Vates TS; Bukowski TP; Fleming P; Freedman AL; Smith CA; Gonzalez R; Perlmutter AD
    J Urol; 1996 Oct; 156(4):1459-62. PubMed ID: 8808907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of oxybutynin treatment on cognition in children with diurnal incontinence.
    Sommer BR; O'Hara R; Askari N; Kraemer HC; Kennedy WA
    J Urol; 2005 Jun; 173(6):2125-7. PubMed ID: 15879864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Individual conditions of pharmacogenic confusion conditions. Comparison of amitriptyline and clozapine].
    Gabriel E; Küfferle B; Lenz G; Schuster P
    Psychiatr Clin (Basel); 1976; 9(1):5-13. PubMed ID: 1019368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of oral anticholinergic therapy in children under 1 years of age with high risk bladder].
    Luque Mialdea R; Martín-Crespo R; Hernández E; Sánchez O; Cañizo A; Fernández A; Aparicio C; Blanco T; Cebrían J
    Cir Pediatr; 2005 Jan; 18(1):3-7. PubMed ID: 15901100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of driptan (oxybutinin) in patients with urgent forms of urination disorders].
    Loran OB; Pushkar' DIu; Tevlin KP
    Urol Nefrol (Mosk); 1998; (6):24-6. PubMed ID: 10051823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment with oxybutynin hydrochloride of urinary incontinence and hyperactive bladder conditions in children].
    Aubert D; Cencig P; Royer M
    Ann Pediatr (Paris); 1986 Sep; 33(7):629-34. PubMed ID: 3777773
    [No Abstract]   [Full Text] [Related]  

  • 39. Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population.
    Palmer LS; Zebold K; Firlit CF; Kaplan WE
    J Urol; 1997 Feb; 157(2):638-40. PubMed ID: 8996387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enuresis].
    Richard M
    Union Med Can; 1971 Sep; 100(9):1814-7. PubMed ID: 5112021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.